Prospective, multicentric, national,observational cohort of patients receiving a systemic treatment for psoriasis

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/45731
• EU PAS number:
  EUPAS32946
• Study ID:
  45731
• Official title and acronym:
  Prospective, multicentric, national,observational cohort of patients receiving a systemic treatment for psoriasis
• DARWIN EU® study:
  No
• Study countries:
  France
• Study status:
  Finalised

Research institutions and networks

Institutions

Multiple centres: 23 centres are involved in the study

Study timelines

Date when funding contract was signed

Actual: 24/02/2012

Study start date

Actual: 07/11/2012

Date of final study report

Planned: 31/12/2021

Actual: 22/10/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Janssen

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable